124 assets in Fallopian Tube Cancer

Therapeutic assets addressing Fallopian Tube Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Navicixizumab Fallopian Tube Cancer	OncXerna Theraputics, Inc.	P3	CCC (52)
Olvimulogene Nanivacirepvec Fallopian Tube Cancer	Genelux Corporation	P3	CCC (52)
Peg-Pei-Cholesterol Lipopolymer Fallopian Tube Cancer	Imunon	P3	CCC (52)
Sacituzumab Tirumotecan Fallopian Tube Cancer	Merck Sharp & Dohme LLC	P3	CCC (52)
Sarilumab Fallopian Tube Cancer	Regeneron Pharmaceuticals	P2	CCC (52)
Ubamatamab Fallopian Tube Cancer	Regeneron Pharmaceuticals	P2	CCC (52)
rc88 Fallopian Tube Cancer	RemeGen Co., Ltd.	P2	CCC (51)
Nemvaleukin Fallopian Tube Cancer	Mural Oncology, Inc	P3	CCC (50)
Polyethyleneglycol-7-Ethyl-10-Hydroxycamptothecin Dfp-13318 Fallopian Tube Cancer	Mayo Clinic	P2	CCC (50)
Upifitamab Rilsodotin Fallopian Tube Cancer	Mersana Therapeutics	P3	CCC (50)
Apsolol Fallopian Tube Cancer	Memorial Sloan Kettering Cancer Center	P1	CCC (49)
Ribociclib Fallopian Tube Cancer	Avenzo Therapeutics, Inc.	P1/2	CCC (49)
Autologous Natural Killer Cell-Like Ctls Fallopian Tube Cancer	Roswell Park Cancer Institute	P1/2	CCC (48)
Bet Bromodomain Inhibitor Zen-3694 Fallopian Tube Cancer	Alexander B Olawaiye, MD	P2	CCC (48)
Gotistobart Fallopian Tube Cancer	OncoC4, Inc.	P2	CCC (48)
hs-20089 Fallopian Tube Cancer	Hansoh BioMedical R&D Company	P2	CCC (48)
Imgn151 Fallopian Tube Cancer	AbbVie	P2	CCC (48)
Mirvetuximab Soravtansine-Gynx Fallopian Tube Cancer	University of Colorado, Denver	P2	CCC (48)
(R)-(1-(4-Fluorophenyl)-6-((1-Methyl-1H-Pyrazol-4-Yl)Sulfonyl)-1,4,5,6,7,8-Hexahydro-4Ah-Pyrazolo(3,4-G)Isoquinolin-4A-Yl)(4-(Trifluoromethyl)Pyridin-2-Yl)Methanone Fallopian Tube Cancer	Corcept Therapeutics	P2	CCC (48)
Romiplostim Fallopian Tube Cancer	Peking University People's Hospital	P2	CCC (48)
Senaparib Fallopian Tube Cancer	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CCC (48)
sg001 Fallopian Tube Cancer	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.	P2	CCC (48)
Tocilizumab Fallopian Tube Cancer	Regeneron Pharmaceuticals	P1/2	CCC (48)
Tretinoin Fallopian Tube Cancer	Peking University People's Hospital	P2	CCC (48)
Utidelone Fallopian Tube Cancer	Beijing Biostar Pharmaceuticals Co., Ltd.	P2	CCC (48)
Azenosertib Fallopian Tube Cancer	OHSU Knight Cancer Institute	P1/2	CC (47)
Palbociclib Fallopian Tube Cancer	Avenzo Therapeutics, Inc.	P1/2	CC (46)
Fractalkine Receptor Antagonist Kand567 Fallopian Tube Cancer	Novakand Pharma AB	P1/2	CC (44)
Oregovamab Fallopian Tube Cancer	CanariaBio Inc.	P2	CC (44)
sl-172154 Fallopian Tube Cancer	Shattuck Labs, Inc.	P1	CC (44)
Atv-1601 Fallopian Tube Cancer	Atavistik Bio, Inc	P1	CC (43)
Berzosertib Fallopian Tube Cancer	National Cancer Institute (NCI)	P1	CC (43)
Cabozantinib Fallopian Tube Cancer	M.D. Anderson Cancer Center	P1	CC (43)
Elimusertib Fallopian Tube Cancer	National Cancer Institute (NCI)	P1	CC (43)
Ipatasertib Fallopian Tube Cancer	National Cancer Institute (NCI)	P1	CC (43)
Prgn-3005 Ultracar-T Cells Fallopian Tube Cancer	Precigen, Inc	P1	CC (43)
23me-00610 Fallopian Tube Cancer	23andMe, Inc.	P1/2	CC (41)
Abemaciclib Fallopian Tube Cancer	Avenzo Therapeutics, Inc.	P1/2	CC (41)
Alnodesertib Fallopian Tube Cancer	Artios Pharma Ltd	P1/2	CC (41)
Avb-001 Fallopian Tube Cancer	Avenge Bio, Inc	P1/2	CC (41)
Avzo-021 Fallopian Tube Cancer	Avenzo Therapeutics, Inc.	P1/2	CC (41)
bat8006 for Fallopian Tube Cancer	Bio-Thera Solutions	P1/2	CC (41)
Deoxycholic Acid Fallopian Tube Cancer	THERAPIM PTY LTD	P1/2	CC (41)
Immunoglobulin G1 [240-Alanine,241-Alanine], Anti-(Human Folate Receptor ?) (Human Monoclonal Pro1184 ?1-Chain, Complex With Human Monoclonal Pro1184 ?-Chain, Dimer, 214??,214???,226,226?,232,232?,235,235?-Octakis(Thioether) With N6-[39-[Bis(1-Deoxy-D-Glucitol-1-Yl)Amino]-1-Oxo-4,7,10,13,16,19,22,25,28,31,34,37-Dodecaoxanonatriacont-1-Yl]-N2-[6-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-1-Oxohexyl]-L-Lysyl-L-Valyl-N5-(Aminocarbonyl)-N-[4-[[[[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]Carbonyl]Oxy]Methyl]Phenyl]-L-Ornithinamide Fallopian Tube Cancer	Genmab	P1/2	CC (41)
Immunoglobulin G2, Anti-(Human Ctla-4 (Antigen)) (Human Monoclonal Cp-675206 Clone 11.2.1 Heavy Chain) Disulphide With Human Monoclonal Cp-675206 Clone 11.2.1 Light Chain, Dimer Fallopian Tube Cancer	New Mexico Cancer Research Alliance	P1/2	CC (41)
Immunoglobulin G4 [237-Proline,242-Proline,243-Valine,244-Alanine,De-245-Glycine], Anti-(Human Mucin-16) (Human Monoclonal Regn5668 ?4-Chain), Disulfide With Human Monoclonal Regn5668 ?-Chain, (235?228?),(238?231?)-Bis(Disulfide) With Immunoglobulin G4 [230-Proline,235-Proline,236-Valine,237-Alanine,De-238-Glycine,436-Arginine,437-Phenylalanine,446-Proline] Anti-(Human Cd28 Antigen) (Human Monoclonal Regn5668 ?4-Chain) Disulfide With Human Monoclonal Regn5668 ?-Chain Fallopian Tube Cancer	Regeneron Pharmaceuticals	P1/2	CC (41)
Mdna11 Fallopian Tube Cancer	Medicenna Therapeutics, Inc.	P1/2	CC (41)
Pasifolate Exatecan Fallopian Tube Cancer	Elucida Oncology	P1/2	CC (41)
Tuvonralimab Fallopian Tube Cancer	Shanghai Gynecologic Oncology Group	P1/2	CC (41)
Cdx-585 Fallopian Tube Cancer	Celldex Therapeutics	P1	CC (40)

Showing 51 to 100 of 124 assets

PreviousPage 2 of 3Next